- Report
- March 2025
- 192 Pages
Global
From €4724EUR$4,950USD£3,958GBP
- Report
- April 2024
- 183 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- January 2025
- 250 Pages
Global
From €4771EUR$4,999USD£3,997GBP
- Report
- April 2022
- 307 Pages
Global
From €5297EUR$5,550USD£4,438GBP
- Report
- September 2023
- 120 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- October 2023
- 190 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- February 2024
- 115 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- April 2023
- 110 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- August 2022
- 116 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- January 2024
- 150 Pages
Global
From €4629EUR$4,850USD£3,878GBP
- Report
- October 2023
- 181 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- January 2024
- 200 Pages
Global
From €3961EUR$4,150USD£3,318GBP
From €2662EUR$2,789USD£2,230GBP

Iron deficiency anemia is a common type of anemia in the field of hematology, characterized by a deficiency of iron in the body that leads to a reduced number of red blood cells and a consequent decrease in their oxygen-carrying capacity. This condition can result from various factors including chronic blood loss, inadequate dietary intake, and problems with iron absorption. Symptoms often include fatigue, weakness, shortness of breath, and pallor. Hematology, the branch of medicine concerned with the study of blood, its producing organs, and blood-related diseases, addresses iron deficiency anemia with a range of diagnostic approaches including complete blood counts, serum ferritin levels, and iron studies. Treatment typically involves iron supplementation, either orally or intravenously, dietary changes, and addressing the underlying causes of iron deficiency.
Several companies are active in the iron deficiency anemia market, providing both therapeutic and diagnostic solutions. Some key players include Akebia Therapeutics, AMAG Pharmaceuticals, Daiichi Sankyo Company, Vifor Pharma, and Shield Therapeutics. These companies engage in the development and marketing of iron supplements, medications to improve iron absorption, and therapies to treat the underlying causes of iron deficiency anemia. Show Less Read more